NASDAQ:KRYS
Krystal Biotech, Inc.
- Stock
Last Close
163.19
16/05 20:00
Market Cap
3.27B
Beta: 0.85
Volume Today
159.41K
Avg: 203.48K
PE Ratio
−105.15
PFCF: −26.48
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.01 - | 0.06 - | |||||||
cash conversion cycle | 431.21 - | ||||||||
cash per share | 0.45 - | 9.25 1,956.83% | 9.98 7.83% | 12.18 22.10% | 14.44 18.54% | 19.74 36.69% | 14.87 24.64% | 19.60 31.76% | |
company equity multiplier | 7.55 - | 1.01 86.58% | 1.03 1.24% | 1.03 0.45% | 1.06 3.31% | 1.06 0.86% | 1.07 1.35% | 1.05 1.72% | |
days of inventory outstanding | 314.72 - | ||||||||
days of payables outstanding | 186.17 - | ||||||||
days of sales outstanding | 302.66 - | ||||||||
dividend yield | |||||||||
ebit per revenue | -11.60 - | -1.92 - | |||||||
ebt per ebit | 1.01 - | 1.66 64.96% | 0.91 44.94% | 0.86 5.40% | 0.97 12.76% | 1.02 4.53% | 0.96 5.39% | -0.13 113.76% | |
effective tax rate | 0.15 - | ||||||||
enterprise value multiple | -39.80 - | -1.43 96.40% | -10.97 665.67% | -32.64 197.65% | -27.95 14.38% | -18.67 33.19% | -16.83 9.88% | -32.73 94.51% | |
fixed asset turnover | 0.34 - | 0.30 - | |||||||
free cash flow per share | -0.31 - | -0.76 146.61% | -1.04 36.30% | -1.58 51.49% | -2.18 37.94% | -5.24 140.47% | -6.02 14.99% | -3.70 38.49% | |
gross profit margin | 1 - | 0.84 - | |||||||
interest coverage | -163.29 - | -1.52 99.07% | -11.60 665.41% | -45.76 - | -27.81 39.23% | ||||
inventory turnover | 1.16 - | ||||||||
long term debt to capitalization | 0.86 - | 0.01 - | 0.01 17.20% | 0.01 3.83% | 0.01 19.71% | 0.01 39.44% | |||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.85 15.24% | |
net profit margin | -10.60 - | 0.22 - | |||||||
operating cash flow per share | -0.31 - | -0.73 136.66% | -0.84 16.18% | -1.18 39.59% | -1.39 17.97% | -2.16 55.56% | -3.95 82.67% | -3.27 17.10% | |
operating cycle | 617.38 - | ||||||||
operating profit margin | -11.60 - | -1.92 - | |||||||
payables turnover | 1.96 - | ||||||||
pretax profit margin | -10.60 - | 0.25 - | |||||||
price fair value | 157.41 - | 1.14 99.28% | 2.06 80.38% | 4.34 111.07% | 3.86 11.07% | 2.62 32.22% | 3.87 47.83% | 4.33 11.88% | |
receivables turnover | 1.21 - | ||||||||
return on assets | -0.53 - | -0.16 70.01% | -0.09 40.66% | -0.09 2.62% | -0.10 13.32% | -0.11 7.34% | -0.25 125.64% | 0.01 105.33% | |
return on capital employed | -0.53 - | -0.10 81.95% | -0.10 8.83% | -0.11 2.27% | -0.11 4.07% | -0.11 1.77% | -0.27 141.16% | -0.12 54.84% | |
return on equity | -3.98 - | -0.16 95.98% | -0.10 39.93% | -0.09 2.18% | -0.11 17.07% | -0.12 6.42% | -0.27 128.69% | 0.01 105.24% | |
total debt to capitalization | 0.86 - | 0.02 - | 0.04 140.35% | 0.01 64.93% | 0.02 26.09% | 0.01 38.83% |
All numbers in USD (except ratios and percentages)